Alessio Pellegrinelli

Alessio Pellegrinelli

Auto-generated profile, based on publicly available information

Alessio Pellegrinelli

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2016 in Neuroendocrinology
Verified
Journal Article
Open access
PDF file
Massimo MilioneMassimo Milione
Massimo Milione
PMPatrick Maisonneuve
Patrick Maisonneuve
FSFrancesca Spada
Francesca Spada
APAlessio Pellegrinelli
Alessio Pellegrinelli
PSPaola Spaggiari
Paola Spaggiari
SRStefano La Rosa
Stefano La Rosa
Background/Aims: Gastroenteropancreatic (GEP) neuroendocrine carcinomas (NECs) are defined as neuroendocrine neoplasms (NENs) with a Ki-67 index >20% according to the 2010 WHO classification. Some reports suggest that this category is heterogeneous. We retrospectively studied a series of 136 patients affected by grade 3 GEP-NECs with the aim to clarify the prognostic role of tumor morphological differentiation, proliferation, defect in mismatch repair proteins (MMRd), CD117 expression, and site of origin. The primary endpoint was the correlation between these parameters and the overall survival (OS). Methods: Univariate and multivariable Cox proportional hazards regression analyses were used to assess the prognostic significance of various clinical and histopathologic features. Results: With a median follow-up of 81 months, the median OS was 12.9 months. At multivariate analysis, morphological differentiation, Ki-67 index, MMRd, stage, and CD117 expression were independent prognostic markers in NECs. Three different prognostic categories of NECs were identified according to the degree of morphologic differentiation (well vs. poorly differentiated) and Ki-67 index (<55% vs. ≥55%). On this basis, median OS was 43.6 months in well-differentiated neoplasms with a Ki-67 index 20-55% (named type A), 24.5 months in poorly differentiated neoplasms with a Ki-67 index 20-55% (type B), and 5.3 months (p < 0.0001) in poorly differentiated neoplasms with a Ki-67 index ≥55% (type C). Conclusions: The present study suggests that GEP-NECs represent a heterogeneous group of neoplasms which can be better classified in different prognostic categories using both tumor morphology and Ki-67 index.

1 March 2017 in European Journal of Cancer
Verified
Journal Article
Closed access
Chiara CremoliniChiara Cremolini
Chiara Cremolini
MCMariaelena Casagrande
Mariaelena Casagrande
FLFotios Loupakis
Fotios Loupakis
GAGiuseppe Aprile
Giuseppe Aprile
FBFrancesca Bergamo
Francesca Bergamo
AFAlfredo Falcone
Alfredo Falcone

23 October 2015 in Histopathology
Verified
Journal Article
Closed access
PDF file
AGAlessandro Del Gobbo
Alessandro Del Gobbo
APAlessio Pellegrinelli
Alessio Pellegrinelli
GGGabriella Gaudioso
Gabriella Gaudioso
MCMassimo Castellani
Massimo Castellani
FMFederica Zito Marino
Federica Zito Marino
SFStefano Ferrero
Stefano Ferrero

4 November 2015 in Targeted Oncology
Verified
Journal Article
Closed access
PDF file
FPFilippo Pietrantonio
Filippo Pietrantonio
FBF. De Braud
F. De Braud
Massimo MilioneMassimo Milione
Massimo Milione
CMClaudia Maggi
Claudia Maggi
RIRoberto Iacovelli
Roberto Iacovelli
MBMaria Di Bartolomeo
Maria Di Bartolomeo

19 December 2013 in Histopathology
Verified
Journal Article
Closed access
PDF file
Massimo MilioneMassimo Milione
Massimo Milione
Patrizia GaspariniPatrizia Gasparini
Patrizia Gasparini
GSgabriella sozzi
gabriella sozzi
VMVincenzo Mazzaferro
Vincenzo Mazzaferro
AFAndrea Ferrari
Andrea Ferrari
GPGiuseppe Pelosi
Giuseppe Pelosi